Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205 - Höhler, Thomas; Hofheinz, Ralf-Dieter (British journal of cancer, 2013)
Gesehen am: 25.09.2014